A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients

The aim of this study was to develop a mechanistic protein-binding model to predict the unbound flucloxacillin concentrations in different patient populations. A mechanistic protein-binding model was fitted to the data using non-linear mixed-effects modelling. Data were obtained from four datasets,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical microbiology and infection 2022-03, Vol.28 (3), p.446.e1-446.e7
Hauptverfasser: Wallenburg, Eveline, Brüggemann, Roger J.M., Roberts, Jason A., Jager, Nynke G.L., Ulldemolins, Marta, Wilkes, Sarah, Schouten, Jeroen, Chin, Paul K.L., ter Heine, Rob
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 446.e7
container_issue 3
container_start_page 446.e1
container_title Clinical microbiology and infection
container_volume 28
creator Wallenburg, Eveline
Brüggemann, Roger J.M.
Roberts, Jason A.
Jager, Nynke G.L.
Ulldemolins, Marta
Wilkes, Sarah
Schouten, Jeroen
Chin, Paul K.L.
ter Heine, Rob
description The aim of this study was to develop a mechanistic protein-binding model to predict the unbound flucloxacillin concentrations in different patient populations. A mechanistic protein-binding model was fitted to the data using non-linear mixed-effects modelling. Data were obtained from four datasets, containing 710 paired total and unbound flucloxacillin concentrations from healthy volunteers, non-critically ill and critically ill patients. A fifth dataset with data from hospitalized patients was used for evaluation of our model. The predictive performance of the mechanistic model was evaluated and compared with the calculation of the unbound concentration with a fixed unbound fraction of 5%. Finally, we performed a fit-for-use evaluation, verifying whether the model-predicted unbound flucloxacillin concentrations would lead to clinically incorrect dose adjustments. The mechanistic protein-binding model predicted the unbound flucloxacillin concentrations more accurately than assuming an unbound fraction of 5%. The mean prediction error varied between –26.2% to 27.8% for the mechanistic model and between –30.8% to 83% for calculation with a fixed factor of 5%. The normalized root mean squared error varied between 36.8% and 69% respectively between 57.1% and 134%. Predicting the unbound concentration with the use of the mechanistic model resulted in 6.1% incorrect dose adjustments versus 19.4% if calculated with a fixed unbound fraction of 5%. Estimating the unbound concentration with a mechanistic protein-binding model outperforms the calculation with the use of a fixed protein binding factor of 5%, but neither demonstrates acceptable performance. When performing dose individualization of flucloxacillin, this should be done based on measured unbound concentrations rather than on estimated unbound concentrations from the measured total concentrations. In the absence of an assay for unbound concentrations, the mechanistic binding model should be preferred over assuming a fixed unbound fraction of 5%.
doi_str_mv 10.1016/j.cmi.2021.06.039
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2550266389</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X21003700</els_id><sourcerecordid>2550266389</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-d0de639b3d3859d0e68a31462dd4e3eb94932b5faf973932e7d0c977f3fbac83</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMorl8_wIv06KU16bRpg6dF_IIFL3vwFtJk6mZJ27VJxfXXm2XVozAww8w7L7wPIZeMZowyfrPOdGeznOYsozyjIA7ICSu4SCkX7DDOTNRpVcDrjJx6v6aU5gDFMZlBkReloHBCzDzpMKhU9cptvfXJ0CabcQho-6SxvbH9227Vukm74VNp61y8xFqhcmG1TT4GN_UBcfSJ6k2yGvzGBuXsF5pko4LFPvhzctQq5_Hip5-R5cP98u4pXbw8Pt_NF6kGwUNqqEEOogEDdSkMRV4riHlyYwoEbEQhIG_KVrWigjhiZagWVdVC2yhdwxm53tvGAO8T-iA76zU6p3ocJi_zsqQ551CLKGV7qR4H70ds5Wa0nRq3klG5YyvXMrKVO7aSchnZxp-rH_up6dD8ffzCjILbvQBjxg-Lo_Q65tdo7Ig6SDPYf-y_Aeupi9o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2550266389</pqid></control><display><type>article</type><title>A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Wallenburg, Eveline ; Brüggemann, Roger J.M. ; Roberts, Jason A. ; Jager, Nynke G.L. ; Ulldemolins, Marta ; Wilkes, Sarah ; Schouten, Jeroen ; Chin, Paul K.L. ; ter Heine, Rob</creator><creatorcontrib>Wallenburg, Eveline ; Brüggemann, Roger J.M. ; Roberts, Jason A. ; Jager, Nynke G.L. ; Ulldemolins, Marta ; Wilkes, Sarah ; Schouten, Jeroen ; Chin, Paul K.L. ; ter Heine, Rob</creatorcontrib><description>The aim of this study was to develop a mechanistic protein-binding model to predict the unbound flucloxacillin concentrations in different patient populations. A mechanistic protein-binding model was fitted to the data using non-linear mixed-effects modelling. Data were obtained from four datasets, containing 710 paired total and unbound flucloxacillin concentrations from healthy volunteers, non-critically ill and critically ill patients. A fifth dataset with data from hospitalized patients was used for evaluation of our model. The predictive performance of the mechanistic model was evaluated and compared with the calculation of the unbound concentration with a fixed unbound fraction of 5%. Finally, we performed a fit-for-use evaluation, verifying whether the model-predicted unbound flucloxacillin concentrations would lead to clinically incorrect dose adjustments. The mechanistic protein-binding model predicted the unbound flucloxacillin concentrations more accurately than assuming an unbound fraction of 5%. The mean prediction error varied between –26.2% to 27.8% for the mechanistic model and between –30.8% to 83% for calculation with a fixed factor of 5%. The normalized root mean squared error varied between 36.8% and 69% respectively between 57.1% and 134%. Predicting the unbound concentration with the use of the mechanistic model resulted in 6.1% incorrect dose adjustments versus 19.4% if calculated with a fixed unbound fraction of 5%. Estimating the unbound concentration with a mechanistic protein-binding model outperforms the calculation with the use of a fixed protein binding factor of 5%, but neither demonstrates acceptable performance. When performing dose individualization of flucloxacillin, this should be done based on measured unbound concentrations rather than on estimated unbound concentrations from the measured total concentrations. In the absence of an assay for unbound concentrations, the mechanistic binding model should be preferred over assuming a fixed unbound fraction of 5%.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1016/j.cmi.2021.06.039</identifier><identifier>PMID: 34245903</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents ; Critical Illness ; Dose individualization ; Floxacillin ; Flucloxacillin ; Healthy Volunteers ; Humans ; Mechanistic model ; Pharmacokinetics ; Protein Binding ; Therapeutic drug monitoring ; Unbound fraction</subject><ispartof>Clinical microbiology and infection, 2022-03, Vol.28 (3), p.446.e1-446.e7</ispartof><rights>2021 The Author(s)</rights><rights>Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-d0de639b3d3859d0e68a31462dd4e3eb94932b5faf973932e7d0c977f3fbac83</citedby><cites>FETCH-LOGICAL-c396t-d0de639b3d3859d0e68a31462dd4e3eb94932b5faf973932e7d0c977f3fbac83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34245903$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wallenburg, Eveline</creatorcontrib><creatorcontrib>Brüggemann, Roger J.M.</creatorcontrib><creatorcontrib>Roberts, Jason A.</creatorcontrib><creatorcontrib>Jager, Nynke G.L.</creatorcontrib><creatorcontrib>Ulldemolins, Marta</creatorcontrib><creatorcontrib>Wilkes, Sarah</creatorcontrib><creatorcontrib>Schouten, Jeroen</creatorcontrib><creatorcontrib>Chin, Paul K.L.</creatorcontrib><creatorcontrib>ter Heine, Rob</creatorcontrib><title>A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>The aim of this study was to develop a mechanistic protein-binding model to predict the unbound flucloxacillin concentrations in different patient populations. A mechanistic protein-binding model was fitted to the data using non-linear mixed-effects modelling. Data were obtained from four datasets, containing 710 paired total and unbound flucloxacillin concentrations from healthy volunteers, non-critically ill and critically ill patients. A fifth dataset with data from hospitalized patients was used for evaluation of our model. The predictive performance of the mechanistic model was evaluated and compared with the calculation of the unbound concentration with a fixed unbound fraction of 5%. Finally, we performed a fit-for-use evaluation, verifying whether the model-predicted unbound flucloxacillin concentrations would lead to clinically incorrect dose adjustments. The mechanistic protein-binding model predicted the unbound flucloxacillin concentrations more accurately than assuming an unbound fraction of 5%. The mean prediction error varied between –26.2% to 27.8% for the mechanistic model and between –30.8% to 83% for calculation with a fixed factor of 5%. The normalized root mean squared error varied between 36.8% and 69% respectively between 57.1% and 134%. Predicting the unbound concentration with the use of the mechanistic model resulted in 6.1% incorrect dose adjustments versus 19.4% if calculated with a fixed unbound fraction of 5%. Estimating the unbound concentration with a mechanistic protein-binding model outperforms the calculation with the use of a fixed protein binding factor of 5%, but neither demonstrates acceptable performance. When performing dose individualization of flucloxacillin, this should be done based on measured unbound concentrations rather than on estimated unbound concentrations from the measured total concentrations. In the absence of an assay for unbound concentrations, the mechanistic binding model should be preferred over assuming a fixed unbound fraction of 5%.</description><subject>Anti-Bacterial Agents</subject><subject>Critical Illness</subject><subject>Dose individualization</subject><subject>Floxacillin</subject><subject>Flucloxacillin</subject><subject>Healthy Volunteers</subject><subject>Humans</subject><subject>Mechanistic model</subject><subject>Pharmacokinetics</subject><subject>Protein Binding</subject><subject>Therapeutic drug monitoring</subject><subject>Unbound fraction</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMorl8_wIv06KU16bRpg6dF_IIFL3vwFtJk6mZJ27VJxfXXm2XVozAww8w7L7wPIZeMZowyfrPOdGeznOYsozyjIA7ICSu4SCkX7DDOTNRpVcDrjJx6v6aU5gDFMZlBkReloHBCzDzpMKhU9cptvfXJ0CabcQho-6SxvbH9227Vukm74VNp61y8xFqhcmG1TT4GN_UBcfSJ6k2yGvzGBuXsF5pko4LFPvhzctQq5_Hip5-R5cP98u4pXbw8Pt_NF6kGwUNqqEEOogEDdSkMRV4riHlyYwoEbEQhIG_KVrWigjhiZagWVdVC2yhdwxm53tvGAO8T-iA76zU6p3ocJi_zsqQ551CLKGV7qR4H70ds5Wa0nRq3klG5YyvXMrKVO7aSchnZxp-rH_up6dD8ffzCjILbvQBjxg-Lo_Q65tdo7Ig6SDPYf-y_Aeupi9o</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>Wallenburg, Eveline</creator><creator>Brüggemann, Roger J.M.</creator><creator>Roberts, Jason A.</creator><creator>Jager, Nynke G.L.</creator><creator>Ulldemolins, Marta</creator><creator>Wilkes, Sarah</creator><creator>Schouten, Jeroen</creator><creator>Chin, Paul K.L.</creator><creator>ter Heine, Rob</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202203</creationdate><title>A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients</title><author>Wallenburg, Eveline ; Brüggemann, Roger J.M. ; Roberts, Jason A. ; Jager, Nynke G.L. ; Ulldemolins, Marta ; Wilkes, Sarah ; Schouten, Jeroen ; Chin, Paul K.L. ; ter Heine, Rob</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-d0de639b3d3859d0e68a31462dd4e3eb94932b5faf973932e7d0c977f3fbac83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents</topic><topic>Critical Illness</topic><topic>Dose individualization</topic><topic>Floxacillin</topic><topic>Flucloxacillin</topic><topic>Healthy Volunteers</topic><topic>Humans</topic><topic>Mechanistic model</topic><topic>Pharmacokinetics</topic><topic>Protein Binding</topic><topic>Therapeutic drug monitoring</topic><topic>Unbound fraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wallenburg, Eveline</creatorcontrib><creatorcontrib>Brüggemann, Roger J.M.</creatorcontrib><creatorcontrib>Roberts, Jason A.</creatorcontrib><creatorcontrib>Jager, Nynke G.L.</creatorcontrib><creatorcontrib>Ulldemolins, Marta</creatorcontrib><creatorcontrib>Wilkes, Sarah</creatorcontrib><creatorcontrib>Schouten, Jeroen</creatorcontrib><creatorcontrib>Chin, Paul K.L.</creatorcontrib><creatorcontrib>ter Heine, Rob</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wallenburg, Eveline</au><au>Brüggemann, Roger J.M.</au><au>Roberts, Jason A.</au><au>Jager, Nynke G.L.</au><au>Ulldemolins, Marta</au><au>Wilkes, Sarah</au><au>Schouten, Jeroen</au><au>Chin, Paul K.L.</au><au>ter Heine, Rob</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2022-03</date><risdate>2022</risdate><volume>28</volume><issue>3</issue><spage>446.e1</spage><epage>446.e7</epage><pages>446.e1-446.e7</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>The aim of this study was to develop a mechanistic protein-binding model to predict the unbound flucloxacillin concentrations in different patient populations. A mechanistic protein-binding model was fitted to the data using non-linear mixed-effects modelling. Data were obtained from four datasets, containing 710 paired total and unbound flucloxacillin concentrations from healthy volunteers, non-critically ill and critically ill patients. A fifth dataset with data from hospitalized patients was used for evaluation of our model. The predictive performance of the mechanistic model was evaluated and compared with the calculation of the unbound concentration with a fixed unbound fraction of 5%. Finally, we performed a fit-for-use evaluation, verifying whether the model-predicted unbound flucloxacillin concentrations would lead to clinically incorrect dose adjustments. The mechanistic protein-binding model predicted the unbound flucloxacillin concentrations more accurately than assuming an unbound fraction of 5%. The mean prediction error varied between –26.2% to 27.8% for the mechanistic model and between –30.8% to 83% for calculation with a fixed factor of 5%. The normalized root mean squared error varied between 36.8% and 69% respectively between 57.1% and 134%. Predicting the unbound concentration with the use of the mechanistic model resulted in 6.1% incorrect dose adjustments versus 19.4% if calculated with a fixed unbound fraction of 5%. Estimating the unbound concentration with a mechanistic protein-binding model outperforms the calculation with the use of a fixed protein binding factor of 5%, but neither demonstrates acceptable performance. When performing dose individualization of flucloxacillin, this should be done based on measured unbound concentrations rather than on estimated unbound concentrations from the measured total concentrations. In the absence of an assay for unbound concentrations, the mechanistic binding model should be preferred over assuming a fixed unbound fraction of 5%.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34245903</pmid><doi>10.1016/j.cmi.2021.06.039</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1198-743X
ispartof Clinical microbiology and infection, 2022-03, Vol.28 (3), p.446.e1-446.e7
issn 1198-743X
1469-0691
language eng
recordid cdi_proquest_miscellaneous_2550266389
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Anti-Bacterial Agents
Critical Illness
Dose individualization
Floxacillin
Flucloxacillin
Healthy Volunteers
Humans
Mechanistic model
Pharmacokinetics
Protein Binding
Therapeutic drug monitoring
Unbound fraction
title A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T04%3A52%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20meta-analysis%20of%20protein%20binding%20of%20flucloxacillin%20in%20healthy%20volunteers%20and%20hospitalized%20patients&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Wallenburg,%20Eveline&rft.date=2022-03&rft.volume=28&rft.issue=3&rft.spage=446.e1&rft.epage=446.e7&rft.pages=446.e1-446.e7&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1016/j.cmi.2021.06.039&rft_dat=%3Cproquest_cross%3E2550266389%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2550266389&rft_id=info:pmid/34245903&rft_els_id=S1198743X21003700&rfr_iscdi=true